Connect with us

Business

What’s Behind the Breakout in Aleafia Health Inc (OTCMKTS:ALEAF)

Published

on

Aleafia Health Inc (OTCMKTS:ALEAF) shares launched higher on Friday on news that the company just announced, along with CannaPacific Pty Ltd., that the two companies have signed a non-binding term sheet in which, upon completion of the transaction, Aleafia will acquire a 10 percent equity stake in CannaPacific.

According to the release, “CannaPacific is a Licensed Australian Medical Cannabis company based in Newcastle and the Macleay Valley on the mid-north coast of NSW, Australia. As at the date of this Term Sheet, CannaPacific has been granted licences to cultivate, produce and research medical cannabis in Australia and has a 53,000 sq. ft. cannabis cultivation and plant research facility currently under construction.”

Aleafia Health Inc (OTCMKTS:ALEAF) promulgates itself as a vertically integrated cannabis company in Canada. The company provides medical consultation services to determine the suitability of medical cannabis in treating patients with chronic pain and other disabling illnesses through operating a medicinal cannabis clinic network under the Canabo Medical Clinic brand.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

It is also involved in the growing, possession, and sale of cannabis products.

Aleafia frames itself as a leading, vertically integrated medical cannabis company with a unique focus on delivering quality patient care from “seed” to “sale.” Aleafia is uniquely positioned with a singular focus on the medical cannabis market. The company operates the largest brick and mortar medicinal cannabis clinic network in Canada under the Canabo Medical Clinic brand, which is staffed by licensed, practicing physicians. Aleafia has obtained over 50,000 unique patients and maintains the largest medical cannabis patient data set in Canada. Aleafia’s state of the art production facilities will allow for the production of high-quality strains at low cost. Aleafia’s production will focus on securing the highest-quality medicinal product for its growing patient base.

Aleafia owns and operates a healthcare clinic that provides medical cannabis therapy to achieve optimum recovery and minimize illness and injury’s cumulative effects.

The company provides medical cannabis therapy, pain management, physiotherapy, chiropractor, osteopathy, registered massage therapy, laser therapy, orthotics, and custom braces and compression socks. It provides consulting and support services for managing cannabis-sensitive cases.

The company assists rehabilitation professionals, case managers, social workers, life care planners, psychologists, family physicians, physiotherapists, litigators, and third-party insurance companies. Aleafia Inc. is based in Concord, Canada.

In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($30.3M against $2.2M).

 

Joining Forces

As we discussed earlier, ALEAF just announced, along with CannaPacific Pty Ltd., that the two companies have signed a non-binding term sheet in which, upon completion of the transaction, Aleafia will acquire a 10 per cent equity stake in CannaPacific.

This announcement has popped the stock higher, which certainly isn’t surprising. ALEAF shareholders are now sitting on about 22% in gains over the past week.

“This strategic investment in an emerging medical cannabis market marks Aleafia’s first step towards a broader global expansion,” said Aleafia Chairman Julian Fantino.

“We are extremely pleased to collaborate with CannaPacific, a company with the team in place to quickly capture market share in Australia,” said Aleafia CEO Geoffrey Benic. “This transaction, once completed, will place Aleafia at the epicenter of what we expect will be a major growth center in the global medical cannabis market.”

Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -11%.

“We are delighted to be partnering with Aleafia,” said CannaPacific CEO Joshua Dennis. “There are clear synergies between the two companies that will create long-term, sustainable value in the Australasian market as we capitalize together on changes in the local regulatory environment. This will allow medical cannabis to play a vital role in lowering the disease burden on patients.”

Aleafia Health Inc (OTCMKTS:ALEAF) managed to rope in revenues totaling $124K in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top-line growth of -85.5%, as compared to year-ago data in comparable terms.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         
Continue Reading
1 Comment

1 Comment

  1. Pingback: What’s Behind the Breakout in Aleafia Health Inc (OTCMKTS:ALEAF) – MMJ REPORTER – Union Verde Sociedad Limitada |

Leave a Reply

Your email address will not be published. Required fields are marked *

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade




FEATURED STORIES

Business9 hours ago

The Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) Roller Coaster Ride Continues

Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) just announced its financial and operational results for the third quarter of fiscal 2018,...

Business9 hours ago

Puration Inc (OTCMKTS:PURA) Catches a Fresh Bid on New Numbers

Puration Inc (OTCMKTS:PURA) just announced its third quarter financial report for the period ending September 30, 2018.  According to the...

Business10 hours ago

Why Expectations May be Dropping for Tilray Inc (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) just reported financial results for the third quarter and nine months ended September 30, 2018. The company...

Business1 day ago

Why OrganiGram Holdings Inc (OTCMKTS:OGRMF) Gets More and More Interesting on the Pullback

OrganiGram Holdings Inc (OTCMKTS:OGRMF) recently announced that the company has signed a supply agreement with the Province of British Columbia....

Business1 day ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Looks for Some More Magic

Namaste Technologies Inc (OTCMKTS:NXTTF) recently announced that the company has acquired over 28,000 registered users through NamasteMD Inc, and that...

Business1 day ago

A Sober Look at Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF)

Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) has presented itself as somewhat of a mystery item in the space. The company...

Business2 days ago

Marimed Inc (OTCMKTS:MRMD) Taps Wall Street Talent for M&A Strategy

Marimed Inc (OTCMKTS:MRMD) recently announced it has named Charles Finnie as its Chief Strategy Officer, effective immediately. Finnie, who most...

Business3 days ago

Why the Latest Dip in New Age Beverages Corp (NASDAQ:NBEV) May Be a Major Gift

New Age Beverages Corp (NASDAQ:NBEV) is starting to drift down into very interesting territory from both a technical and a...

Business3 days ago

Pyxus International Inc (NYSE:PYX) Could be an Opportunity in the Making

Pyxus International Inc (NYSE:PYX) shares were hammered to close out the week after announcing relatively dreadful fiscal Q2 results, which...

Business4 days ago

Aurora Cannabis Inc (NYSE:ACB) Shares Rebound as Company Turns Focus to South American Market

Aurora Cannabis Inc (NYSE:ACB) just acquired ICC Labs, or so appears to be the case. As a point in fact,...

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play